Stock CELC CELCUITY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Celcuity Inc.

Equities

CELC

US15102K1007

Market Closed - Nasdaq
Other stock markets
 21:00:00 21/06/2024 BST 		5-day change 1st Jan Change
15.93 USD +2.31% Intraday chart for Celcuity Inc. +5.99% +9.33%
05-31 Needham Trims Price Target on Celcuity to $23 From $24, Maintains Buy Rating MT
05-30 Sector Update: Health Care Stocks Mixed Pre-Bell Thursday MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Celcuity To Participate in Jefferies Global Healthcare Conference
AQ
Celcuity Announces Pricing of Underwritten Common Stock Offering
AQ
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
AQ
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
AQ
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
AQ
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
AQ
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
AQ
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
AQ
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
AQ
Celcuity to Participate in Cowen’s 44th Annual Health Care Conference
AQ
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer
AQ
Celcuity Appoints Eldon Mayer as Chief Commercial Officer
AQ
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium
AQ
Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium
AQ
Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference
AQ
Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
AQ
Celcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Call
AQ
Celcuity To Present at Upcoming Stifel and Jefferies Investor Conferences
AQ
Celcuity Inc. Announces $50 Million Private Placement
AQ
Celcuity : Science Day Presentation
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CELC Stock
  4. News Celcuity Inc.
  5. Press Releases